BR112015019430A8 - composições farmacêuticas para a cicatrização de ferimentos e uso das mesmas - Google Patents

composições farmacêuticas para a cicatrização de ferimentos e uso das mesmas Download PDF

Info

Publication number
BR112015019430A8
BR112015019430A8 BR112015019430A BR112015019430A BR112015019430A8 BR 112015019430 A8 BR112015019430 A8 BR 112015019430A8 BR 112015019430 A BR112015019430 A BR 112015019430A BR 112015019430 A BR112015019430 A BR 112015019430A BR 112015019430 A8 BR112015019430 A8 BR 112015019430A8
Authority
BR
Brazil
Prior art keywords
wound
wound healing
film
present
forming
Prior art date
Application number
BR112015019430A
Other languages
English (en)
Other versions
BR112015019430A2 (pt
Inventor
Hwan Kim Dae
Ho Jun Joon
Won Son Mi
Dug Han Sang
Hoe Kim Soon
Woo Jang Sun
Rak Choi Sung
Sam Kwon Yong
Sung Sohn Yong
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Publication of BR112015019430A2 publication Critical patent/BR112015019430A2/pt
Publication of BR112015019430A8 publication Critical patent/BR112015019430A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

resumo “composição farmacêutica formadora de película para curar ferimento e método para a sua preparação” a presente invenção se refere a uma composição farmacêutica para formação de uma película diretamente sobre um ferimento para acelerar a cura do ferimento, um uso para a mesma, um método de tratamento usando a mesma e um método para a preparação da mesma. a composição formadora de película de acordo com a presente invenção forma uma película diretamente sobre o ferimento para aumentar a adesão ao ferimento. a película hidrófila delgada formada protege a superfície do ferimento para impedir a infecção da superfície do ferimento, para reter a substância ativa do ponto de vista fisiológico útil para a cura do ferimento sobre a superfície do ferimento para promover a cura do ferimento, e para permitir que os medicamentos sejam continuamente fornecidos à superfície do ferimento. portanto, a composição de acordo com a presente invenção tem um efeito excelente de cura de ferimento e tem uma excelente capacidade de utilização, uma vez que não é absorvida na roupa, curativo etc., substituindo efetivamente assim formações convencionais em gel ou unguento para o fornecimento de substâncias ativas do ponto de vista fisiológico.
BR112015019430A 2013-02-13 2014-02-11 composições farmacêuticas para a cicatrização de ferimentos e uso das mesmas BR112015019430A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130015400A KR101457789B1 (ko) 2013-02-13 2013-02-13 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
PCT/KR2014/001103 WO2014126370A1 (en) 2013-02-13 2014-02-11 Film-forming pharmaceutical composition for wound healing and method for preparing the same

Publications (2)

Publication Number Publication Date
BR112015019430A2 BR112015019430A2 (pt) 2017-07-18
BR112015019430A8 true BR112015019430A8 (pt) 2019-11-05

Family

ID=51354331

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015019430A BR112015019430A8 (pt) 2013-02-13 2014-02-11 composições farmacêuticas para a cicatrização de ferimentos e uso das mesmas

Country Status (6)

Country Link
US (1) US10278928B2 (pt)
EP (1) EP2956126B1 (pt)
KR (1) KR101457789B1 (pt)
CN (1) CN104994843B (pt)
BR (1) BR112015019430A8 (pt)
WO (1) WO2014126370A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10111956B2 (en) * 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
US20150005391A1 (en) 2013-06-26 2015-01-01 COLE Research & Design, Inc. Method of reducing scarring
KR101538846B1 (ko) 2013-07-30 2015-07-22 동아에스티 주식회사 신규한 바이페닐 유도체 및 그의 제조방법
WO2015186058A1 (en) * 2014-06-03 2015-12-10 Stellenbosch University Method for preventing or treating microbial growth on a manufactured product
WO2016057831A1 (en) * 2014-10-10 2016-04-14 COLE Research & Design, Inc. Method of reducing scarring
EP4070723A1 (en) 2015-09-18 2022-10-12 Auris Health, Inc. Navigation of tubular networks
CN106619485A (zh) * 2015-11-02 2017-05-10 西安艾姆高分子材料有限公司 有机纳米级烧伤、烫伤、创伤快速修复膏
US10099995B2 (en) 2015-12-24 2018-10-16 Cole Research and Design, LLC Resveratrol esters
KR101825041B1 (ko) * 2016-04-07 2018-02-02 주식회사 바이오솔루션 물질 p를 포함하는 상처치유용 약학 조성물
CN107519182A (zh) * 2016-06-20 2017-12-29 天津金耀集团有限公司 以丁酸氢化可的松为活性成分的皮肤药物组合物
KR101921727B1 (ko) * 2016-12-28 2018-11-23 주식회사 제네웰 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제
EP3568121A1 (en) * 2017-01-13 2019-11-20 Primex Ehf. Chitosan-containing formulations and methods of making and using the same
CN106822988B (zh) * 2017-02-08 2019-12-31 中英阿诺康（宁夏）生物科技有限公司 海藻纤维功能性敷料及其应用、海藻纤维功能性敷料贴
CN108186711A (zh) * 2017-02-27 2018-06-22 彭伟东 促进伤口愈合的药物组合物
WO2019016705A1 (pt) * 2017-07-19 2019-01-24 Universidade Da Beira Interior Pelicula para aplicação tópica no tratamento de lesões da pele e método para sua obtenção e aplicação
KR102548058B1 (ko) * 2017-09-12 2023-06-26 실파 메디케어 리미티드 슬관절 치환술을 위한 트라넥삼산 스프레이
WO2019080983A1 (fr) * 2017-10-26 2019-05-02 Hassiba Laribi Habchi Nouvelle formulation a base de chitosane et son procede de preparation.
CN108245709A (zh) * 2017-12-13 2018-07-06 上海昊海生物科技股份有限公司 一种预防包膜挛缩的仿生型几丁糖填充剂及其制备方法
CN108126236B (zh) * 2017-12-20 2021-01-01 浙江科技学院 一种医药涂敷材料及其制备方法
KR102117582B1 (ko) * 2018-03-07 2020-06-02 단국대학교 천안캠퍼스 산학협력단 피부 투과성이 향상된 후시딘산 함유 필름 형성 외용겔
WO2020112590A1 (en) * 2018-11-27 2020-06-04 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Solubilised centella asiatica extract
CN112121146B (zh) * 2019-06-25 2021-08-06 山东瑞安药业有限公司 一种用于皮肤创伤的外用凝胶剂及其制备方法
JP7441943B2 (ja) * 2019-10-24 2024-03-01 ヴィシャガン ヴァナンガムディ スラー 細菌感染および創傷治癒のための医薬組成物を含む局所的抗生物質
CN110898038A (zh) * 2019-12-13 2020-03-24 厦门肽王基因科技有限公司 一种鲨鱼肽凝胶涂膜剂及其制备方法
CN110974810B (zh) * 2019-12-24 2023-10-17 重庆铭仁堂怡和中医诊所有限公司 成膜型护创液及其制备方法与应用
KR102385533B1 (ko) 2020-03-03 2022-04-11 인하대학교 산학협력단 산소 발생 상처 피복재 및 이의 제조 방법
CN111437392A (zh) * 2020-04-22 2020-07-24 卢丽菊 一种生物医药创面消炎水
CN111991612A (zh) * 2020-08-29 2020-11-27 山东百多安医疗器械股份有限公司 一种具有镇痛、抗菌功能的液体敷料制备方法
CN112402687A (zh) * 2020-11-26 2021-02-26 嘉应学院 一种广东紫珠液体创可贴及其制备方法
CN113995736A (zh) * 2021-11-01 2022-02-01 浙江仲兴生物医药科技有限公司 一种用于创面愈合的三叶青喷雾膜剂及其制备方法
CN114668898A (zh) * 2022-03-25 2022-06-28 中山大学 脂肪乳在制备创伤修复材料中的应用
CN115025070B (zh) * 2022-05-30 2024-02-09 浙江大学 一种快速自成膜抗感染镇痛喷剂及其制备方法和应用
US20240041901A1 (en) * 2022-08-02 2024-02-08 TF Holdings LLC Wound treatment topical composition containing cannabinoids
CN115887747B (zh) * 2022-10-22 2024-02-20 湖南中腾湘岳生物科技有限公司 一种含有纳米孔隙柔性膜的液体创口保护材料及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
JPH0818983B2 (ja) 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
DE4429285C1 (de) 1994-08-18 1995-10-12 Siemens Ag Ansteuerschaltung für ein feldeffektgesteuertes Leistungs-Halbleiterbauelement
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
EP1179352A1 (en) 2000-08-08 2002-02-13 MONTERESEARCH S.r.l. Topical composition for covering a skin lesion
KR20020066024A (ko) 2001-02-08 2002-08-14 굿젠 주식회사 수용성 키토산과 헤파린으로 이루어진 상처 치유 촉진연고 조성물과 필름 및 제품
GB0126923D0 (en) * 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
KR100440239B1 (ko) 2002-01-09 2004-07-15 한국원자력연구소 상처 치료용 수화겔의 제조방법
KR100608192B1 (ko) 2003-04-16 2006-08-02 주식회사 효성 창상 피복재 및 조직공학 구조체용 중화 키토산 스폰지제조방법 및 이에 의해 제조된 중화 키토산 스폰지
KR20060015215A (ko) * 2004-08-13 2006-02-16 류 성 렬 Chitosan를 이용한 피부 화상-상처 치료제 개발
KR100644369B1 (ko) 2004-10-25 2006-11-10 한국화학연구원 피부드레싱용 키토산-젤라틴-알진 스폰지 및 이의 제조방법
NZ566401A (en) 2005-09-29 2011-03-31 Novartis Ag Topical antifungal compositions of terbinafine with hydroxypropylcellulose and an octylacrylamide acrylate copolymer
KR100748390B1 (ko) 2005-11-14 2007-08-10 주식회사 대웅 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형
KR100979347B1 (ko) 2009-03-25 2010-08-31 삼일제약주식회사 항진균 조성물
CN102427802A (zh) * 2009-04-13 2012-04-25 苏鲁·苏布拉马尼·瓦南加穆迪 使用磺胺嘧啶银和壳聚糖制备的药用乳膏以及其制备方法
US8895542B2 (en) * 2009-04-13 2014-11-25 Vanangamudi Subramaniam Sulur Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
KR20110027434A (ko) 2009-09-10 2011-03-16 보람제약주식회사 약물의 서방출이 가능한 발수필름 형성용 조성물
KR20110074116A (ko) * 2009-12-24 2011-06-30 애경산업(주) 상처치유용 조성물 및 이의 제조방법
KR101180174B1 (ko) 2010-04-23 2012-09-05 동아제약주식회사 신규한 벤즈아미드 유도체
WO2012070701A1 (ko) 2010-11-24 2012-05-31 동아제약주식회사 퀴놀린 유도체 화합물, 이의 제조방법 및 이를 포함하는 약학 조성물
US20130317052A1 (en) 2010-11-24 2013-11-28 Dong-A St Co., Ltd. Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same
KR101341692B1 (ko) 2011-03-16 2013-12-20 동아에스티 주식회사 복합생약추출물을 함유하는 당뇨병성 말초 신경병증의 치료 및 예방을 위한 조성물
KR101341693B1 (ko) 2011-03-16 2013-12-16 동아에스티 주식회사 생약추출물을 함유하는 퇴행성 신경질환의 치료 및 예방을 위한 조성물
CN103006923B (zh) * 2012-12-26 2014-05-14 杨桂香 一种中药液体创可贴及制备方法

Also Published As

Publication number Publication date
BR112015019430A2 (pt) 2017-07-18
KR101457789B1 (ko) 2014-11-03
WO2014126370A1 (en) 2014-08-21
US20150374641A1 (en) 2015-12-31
EP2956126B1 (en) 2023-04-05
KR20140102026A (ko) 2014-08-21
US10278928B2 (en) 2019-05-07
CN104994843B (zh) 2020-07-07
EP2956126A1 (en) 2015-12-23
CN104994843A (zh) 2015-10-21
EP2956126A4 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
BR112015019430A8 (pt) composições farmacêuticas para a cicatrização de ferimentos e uso das mesmas
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
BR112016015838A8 (pt) compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação
BR112018003845A2 (pt) auxiliares cirúrgicos com medicamentos afetados por materiais ativadores
BR112013006953A2 (pt) composto, composições farmacêutica e anti-helmíntica, uso de um composto, kit, e, método de tratamento de uma doença
BR112015028879A8 (pt) compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
BR112015008480A2 (pt) compostos de benzeno substituído
BR112017023764A2 (pt) derivados de ciclohexano substituído por amido
BR112016013832A2 (pt) Uso de análogo e/ou derivado de insulina, formulação farmacêutica e processo para a preparação da mesma, kit e dispositivo médico
BR112015007814A2 (pt) diagnóstico, prevenção e tratamento de doenças da articulação
BR112015019412A2 (pt) inibidores de bace1
BR112016028845A2 (pt) composto, composição farmacêutica e uso de um composto
CL2019001586A1 (es) Insulina que contiene composiciones farmacéuticas.
BR112015011898A2 (pt) forma cristalina a da chidamida, método para preparar a forma cristalina a da chidamida, uso da forma cristalina a da chidamida, forma cristalina b da chidamida, método para preparar a forma cristalina b da chidamida, uso da forma cristalina b da chidamida e formulação farmacêutica para o tratamento de doenças relacionadas à diferenciação e proliferação celular
CL2012002560A1 (es) Metodos para el tratamiento de ulceras de pie diabetico que comprende un peptido de al menos 5 aminoacidos contiguos de nle3 a(1-7) efectivo; formulacion farmacéutica que comprende hidroxietil celulosa (hec) y un peptido de al menos 5 aminoacidos contiguos de nle3 a(1-7).
BR112017022757A2 (pt) derivados do pirazol úteis como inibidores da proteína ativadora da 5-lipoxigenase (flap)
BR112016027435A2 (pt) formulação inovadora de meloxicam
BR112014032583A2 (pt) forma farmacêutica para liberação prolongada de substâncias ativas
CO2021013251A2 (es) Derivados de insulina sensibles a la glucosa
BR112015021265A2 (pt) métodos de aperfeiçoamento de uso para secretoglobinas humanas recombinantes
BR112016000092A2 (pt) nanopartículas lipídicas para a cicatrização de feridas
BR112015027984A2 (pt) Agonistas alfa adrenérgicos para o tratamento de lesão de tecido
BR112018008076A2 (pt) derivados de lapachona contendo dois centros redox e métodos de uso dos mesmos
BR112019018028A2 (pt) Composto, combinação, e. uso de um composto ou um sal farmaceuticamente aceitável do mesmo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]